/Investor DB

Tin Alley Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Founder)inThomas Oxley(Founder)inTom Oxley(Founder)

BoardRahul Sharma(Director)Alex Morgan(Director)in

Co-investorsAlumni VenturesARCH Venture PartnersForepont Capital PartnersID8 InvestmentsIn-Q-TelK2 Global+15 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.